Live Breaking News & Updates on Rebekka Wittrahm

Stay updated with breaking news from Rebekka wittrahm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

A protein modification of MECP2 can convey neuroprotection under inflammation


 E-Mail
Credit: UEF/ Raija Törrönen
Researchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a therapeutic target in early Alzheimer s disease. The new study investigated the role of MECP2, a regulator of gene expression, in Alzheimer s disease related processes in brain cells. The study found that phosphorylation of MECP2 protein at a specific amino acid decreases in the brain as Alzheimer s disease is progressing. Abolishing this phosphorylation of MECP2 in cultured mouse neurons upon inflammatory stimulation enhanced their viability and increased the expression of important genes in the maintenance and protection of neurons. The results obtained in the study call attention to modifications of MECP2 as potential targets for developing specific therapies against AD and other neurodegenerative diseases. The study was recently published in the ....

Norra Savolax , Rebekka Wittrahm , Mari Takalo , Mikko Hiltunen , Institute Of Biomedicine , Academy Of Finland , University Of Eastern Finland , Eastern Finland , Early Stage Researcher Rebekka , Professor Mikko Hiltunen , Sigrid Jus , Strategic Neuroscience Funding , European Union , Stage Researcher Rebekka Wittrahm , Researcher Mari Takalo , Medicine Health , Alzheimers Disease , கலைக்கழகம் ஆஃப் பின்லாந்து , பல்கலைக்கழகம் ஆஃப் கிழக்கு பின்லாந்து , கிழக்கு பின்லாந்து , ஐரோப்பிய தொழிற்சங்கம் , மருந்து ஆரோக்கியம் ,